Ponatinib treatment promotes arterial thrombosis and hyperactive platelets

Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Merkulova, Alona, Mitchell, Steven C., Stavrou, Evi X., Forbes, Gabriel L., Schmaier, Alvin H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2019
Konular:
Stimulus Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693004/
https://ncbi.nlm.nih.gov/pubmed/31383636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000034
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller